Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Immune Globulin

Promising Alzheimer’s Drug Fails in Study

Baxter International Inc. says that a blood product it was testing failed to slow mental decline or to preserve physical function in a major study of 390 patients with mild to moderate Alzheimer’s disease.

The company says that people who received 18 months of infusions with its drug, Gammagard, fared no better than others… Promising Alzheimer’s Drug Fails in Study   



I have Alzheimer Disease

amyloid beta 42 peptide1 - symptoms of dementia3 - 1 - alzheimer's warning signs1 - beta amyloid protein1 - parkinson’s disease2 - broken bones1 - brain amyloid imaging1 - brain health1 - fatuitas1 - memory7 - reverse cholesterol transport1 - sobrino1 - mild dementia2 - progressive movement disorder2 - alzheimer's process1 - hay fever1 - gammagard1 - mild tremor1 - alzheimer's signs1 - chuanhai cao1 - vci1 - prion disease1 - entorhinal cortex1 - gum disease1 - sign of alzheimer's1 - ipscs1 - physical reality1 - amyloid-beta plaque1 - omega-3s1 -